Off-label prescribing during pregnancy

被引:23
|
作者
Rayburn, WF
Farmer, KC
机构
[1] UNIV OKLAHOMA,HLTH SCI CTR,DEPT PHARMACOL & TOXICOL,OKLAHOMA CITY,OK 73190
[2] UNIV OKLAHOMA,HLTH SCI CTR,COLL PHARM,DEPT PHARM PRACTICE,OKLAHOMA CITY,OK 73190
关键词
D O I
10.1016/S0889-8545(05)70317-X
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Off-label drug use occurs when physicians prescribe a drug for indications other than those listed on the product label or package insert. Although off-label uses are usually based on clinical studies, these potentially useful therapies have not been approved by the Food and Drug Administration (FDA). Clinicians opposed to off-label drug use express concern that the potential risks may be the same or even greater relative to the benefits. Pregnancy poses a unique situation with regard to off-label drug use. Conceptually, treatment of the mother and fetus can be approached independently; however, from a practical viewpoint, neither can be treated alone, which can represent a conflict of interest. A drug prescribed in an off-label manner should not ''just be tried out'' but used to answer the question ''does it really work?''
引用
收藏
页码:471 / &
页数:9
相关论文
共 50 条
  • [1] Off-label prescribing during pregnancy in France: the NeHaVi cohort
    Laroche, Marie-Laure
    Blin, Aurora
    Coubret, Anne
    Grau, Muriel
    Roux, Barbara
    Aubard, Yves
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2020, 58 (04) : 198 - 207
  • [2] Off-label prescribing
    Raknes, Guttorm
    [J]. TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2016, 136 (04) : 335 - 335
  • [3] Off-label prescribing
    Gazarian, Madlen
    Morris, Steve
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2014, 200 (11) : 637 - 637
  • [4] Off-label prescribing
    Seale, J. Paul
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2014, 200 (02) : 65 - 65
  • [5] Off-label prescribing
    Kelly, Maria
    Gazarian, Madlen
    McPhee, John
    [J]. AUSTRALIAN PRESCRIBER, 2005, 28 (01) : 7 - 7
  • [6] OFF-LABEL PRESCRIBING OF ANTIDEPRESSANTS Robust systems are needed for off-label prescribing
    Ross, Samantha
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2017, 356
  • [7] The Perils of Off-Label Prescribing
    Buppert, Carolyn
    [J]. JNP-JOURNAL FOR NURSE PRACTITIONERS, 2012, 8 (07): : 567 - 568
  • [8] Off-label prescribing in oncology
    Susan G. Poole
    Michael J. Dooley
    [J]. Supportive Care in Cancer, 2004, 12 : 302 - 305
  • [9] Off-Label Prescribing: Justified or Not?
    Ruan, Xiulu
    Kaye, Alan David
    [J]. AMERICAN JOURNAL OF MEDICAL QUALITY, 2016, 31 (02) : 101 - 102
  • [10] The challenge of off-label prescribing
    Phillips, Jane
    [J]. INTERNATIONAL JOURNAL OF PALLIATIVE NURSING, 2015, 21 (09) : 419 - 419